1. Home
  2. LSTA vs CXAI Comparison

LSTA vs CXAI Comparison

Compare LSTA & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • CXAI
  • Stock Information
  • Founded
  • LSTA 1980
  • CXAI N/A
  • Country
  • LSTA United States
  • CXAI United States
  • Employees
  • LSTA N/A
  • CXAI N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • CXAI EDP Services
  • Sector
  • LSTA Health Care
  • CXAI Technology
  • Exchange
  • LSTA Nasdaq
  • CXAI Nasdaq
  • Market Cap
  • LSTA 31.2M
  • CXAI 33.9M
  • IPO Year
  • LSTA N/A
  • CXAI N/A
  • Fundamental
  • Price
  • LSTA $2.51
  • CXAI $1.61
  • Analyst Decision
  • LSTA Strong Buy
  • CXAI
  • Analyst Count
  • LSTA 1
  • CXAI 0
  • Target Price
  • LSTA $15.00
  • CXAI N/A
  • AVG Volume (30 Days)
  • LSTA 58.9K
  • CXAI 882.7K
  • Earning Date
  • LSTA 02-27-2025
  • CXAI 11-12-2024
  • Dividend Yield
  • LSTA N/A
  • CXAI N/A
  • EPS Growth
  • LSTA N/A
  • CXAI N/A
  • EPS
  • LSTA N/A
  • CXAI N/A
  • Revenue
  • LSTA N/A
  • CXAI $7,200,000.00
  • Revenue This Year
  • LSTA N/A
  • CXAI $3.86
  • Revenue Next Year
  • LSTA N/A
  • CXAI $100.00
  • P/E Ratio
  • LSTA N/A
  • CXAI N/A
  • Revenue Growth
  • LSTA N/A
  • CXAI N/A
  • 52 Week Low
  • LSTA $2.19
  • CXAI $1.09
  • 52 Week High
  • LSTA $4.20
  • CXAI $7.07
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 40.33
  • CXAI 47.82
  • Support Level
  • LSTA $2.51
  • CXAI $1.46
  • Resistance Level
  • LSTA $2.66
  • CXAI $1.64
  • Average True Range (ATR)
  • LSTA 0.19
  • CXAI 0.10
  • MACD
  • LSTA -0.01
  • CXAI 0.01
  • Stochastic Oscillator
  • LSTA 17.50
  • CXAI 82.61

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About CXAI CXApp Inc.

CXApp Inc is a workplace experience platform for enterprise customers. It is a SaaS product for enterprise organizations, distributing a mobile app to all employees within the organization. It includes a content management system (or CMS) so customers can adjust configurations for their workplace settings autonomously and spontaneously. Its technologies and solutions help enterprise customers deliver a comprehensive business journey in a work 'from anywhere' world for employees, partners, customers, and visitors. CXApp offers native mapping, analytics, on-device positioning (or ODP), and application technologies that bring people together.

Share on Social Networks: